Aurora Cannabis (NASDAQ:ACB) Posts Quarterly Earnings Results, Beats Expectations By $0.15 EPS

Aurora Cannabis (NASDAQ:ACB) posted its quarterly earnings data on Wednesday. The company reported $0.06 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.09) by $0.15, Zacks reports. Aurora Cannabis had a negative return on equity of 2.19% and a negative net margin of 17.47%.

Aurora Cannabis Trading Up 46.7 %

Shares of ACB traded up $1.72 during trading hours on Wednesday, hitting $5.40. The stock had a trading volume of 37,816,741 shares, compared to its average volume of 2,240,929. Aurora Cannabis has a 12-month low of $2.84 and a 12-month high of $9.35. The firm has a market cap of $296.24 million, a P/E ratio of -7.06 and a beta of 1.85. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.88 and a current ratio of 3.83. The company’s fifty day simple moving average is $4.19 and its 200 day simple moving average is $5.16.

Wall Street Analysts Forecast Growth

ACB has been the topic of a number of research analyst reports. TD Cowen started coverage on Aurora Cannabis in a research note on Wednesday, December 11th. They issued a “buy” rating on the stock. TD Securities raised shares of Aurora Cannabis to a “strong-buy” rating in a research report on Thursday, December 12th.

Aurora Cannabis Company Profile

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.